WWL123
WWL123, a carbamate-based compound, is a potent and selective ABHD6 inhibitor. WWL123 can be used for research of inflammation, metabolic disorders (obesity and type II diabetes mellitus) and epilepsy[1].
Product Specifications
CAS Number
1338574-83-6
UNSPSC
12352005
Target
MAGL
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/wwl123-1.html
Purity
98.0
Solubility
DMSO : 1 mg/mL (ultrasonic; warming)
Smiles
O=C(C1=CC=C(C2=CC=C(OC(N(CC3=CC=CC(C4=CC=CC=C4)=C3)C)=O)C=C2)C=C1)N
Molecular Formula
C28H24N2O3
Molecular Weight
436.50
References & Citations
[1]Patel JZ, et al. Revisiting 1,3,4-Oxadiazol-2-ones: Utilization in the Development of ABHD6 Inhibitors. Bioorg Med Chem. 2015 Oct 1;23 (19) :6335-45.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
